Hydroxyurea-Induced Interstitial Pneumonitis

A Rare Clinical Entity

Autores/as

  • Palwasha Kamal, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine
  • Muhammad Imran, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine; Division of Allergy, Clinical Immunology, & Rheumatology
  • Ayesha Irum, MBBS University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine
  • Heath Latham, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine; Division of Pulmonary and Critical Care
  • Julian Magadan III, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine; Division of Allergy, Clinical Immunology, & Rheumatology

DOI:

https://doi.org/10.17161/kjm.v10i2.8653

Palabras clave:

interstitial lung diseases, hydroxyurea, hypersensitivity

Métricas

##plugins.generic.paperbuzz.sourceName.fileDownloads##
322
Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026
|

Descargas

Publicado

2019-01-14

Número

Vol. 10 Núm. 2 (2017)

Sección

Case Reports

Licencia

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

Cómo citar

Kamal, P., Imran, M., Irum, A., Latham, H., & Magadan III, J. (2019). Hydroxyurea-Induced Interstitial Pneumonitis: A Rare Clinical Entity. Kansas Journal of Medicine, 10(2), 47-49. https://doi.org/10.17161/kjm.v10i2.8653